The Label Says “X”: The Patient Hears “Y” (and Everyone Pays for the Misread)
There’s a special kind of quiet chaos that happens when a medicine label is misread. It’s rarely malicious. More often
General
You’re Not Wrong to Worry: The Chronic-Use Anxiety Questions People Ask Before They Ask Their Clinician
There comes a point in chronic treatment—whether it’s a pill, a monthly injection, or a daily inhaler—when the anxiety isn’t
Forget the ‘just stop’ urge: the most common ‘do I need to taper this?’ withdrawal-risk myths
There’s a particular kind of confidence that shows up right when someone is feeling better—then decides it’s time to “just
The “Natural” and the “Not So Natural”: A Field Guide to Common Supplement + Prescription Interaction Myths
Some interactions are dramatic—two drugs collide, a vital mechanism flares, and a patient ends up in the wrong storyline. But
The OTC/Prescription Double-Dip: How People Accidentally Take the Same Drug Twice (And Why It’s Not Just “Missing the Label”)
Every so often, the pharmacy call that makes you wince isn’t for a rare reaction or a mysterious lab result.
The Brand-Generic Confusion Playbook: 40 Questions People Ask Before They Switch
If you’ve ever stared at a prescription that says one name and a pharmacy label that gives you another, you’re
The Questions Patients Ask When a Pill Won’t Cooperate
Medication adherence is less about willpower than friction—and patients feel that friction online. Every day, people with chronic conditions go
AI Monitoring for Pharmacovigilance: How Drug Companies Track Mentions Before Regulators Do
The standard pharmacovigilance process has a timing problem Adverse events travel faster than case reports. A patient posts about a
What Happens When Investors Ask AI About Your Company? For Biopharma, the Answer Is Often Wrong, Outdated, or Missing Entirely
An investor researching a biopharmaceutical company in 2026 is more likely to open ChatGPT, Perplexity, or Gemini than to read
The Untracked Layer of Pharma Competitive Intelligence: What People Actually Ask AI
The short answer: Most pharma competitive intelligence still runs on search rankings, social listening, and claims data. None of that
What If Your Competitive Intelligence Started With What People Actually Ask?
Fifty-one percent of US adults now say they use an AI chatbot such as ChatGPT, Gemini, or Copilot, up from
Profound, Peec, and Scrunch Can Tell You AI Mentioned Your Drug. None of Them Can Tell You If the Mention Was Legal.
Six tools now dominate the market for tracking how brands show up in ChatGPT, Perplexity, Gemini, and Google’s AI Overviews:
